通过PI3K-mTOR途径阻碍斑马鱼的肌肉发育
Yong Huang1, Runhao Zhu2, Yan Lei3
1State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, Jiangxi 330000, China.
Ecotoxicology and environmental safety
|September 2, 2025
概括
通过抑制关键肌源性因素和PI3K- mTOR通路,甲基 (PP) 暴露会损害斑马鱼的肌肉发育和功能. 恢复这种途径可以减轻先天性肌肉病的防腐剂诱导的肌肉毒性.
科学领域:
- 肌肉生物学
- 毒理学
- 发育生物学
背景情况:
- 遗传性肌肉病是一种遗传性肌肉疾病.
- 环境中的毒素可能会加剧这种情况.
- 甲 (PP) 的肌肉毒性尚不清楚.
研究的目的:
- 研究PP的肌肉毒性机制.
- 使用Tg (-1.9mylpfa:EGFP) 的斑马鱼模型.
- 探索PP对肌肉发育和行为的影响.
主要方法:
- 斑马鱼的成像和行为分析.
- 定量PCR (qPCR) 和现场杂交.
- 评估PI3K-mTOR路径和ROS水平
主要成果:
- PP 损害了肌肉纤维和前体细胞的发展.
- 减少幼虫运动和表现.
- PP抑制了MyoD,Myf5,PI3K- mTOR通路,并增加了ROS.
- 通过 mTOR 激活器挽救了 PP 引起的毒性.
结论:
- 通过MyoD/ Myf5抑制和PI3K- mTOR抑制诱导肌肉毒性.
- 环境防腐剂可能会加剧遗传性肌肉疾病.
- 针对PI3K-mTOR途径提供治疗潜力.
相关概念视频
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...


